Prenetics is about to launch a medical molecular testing product, Circle Medical, targeting doctors. This product is comparable to Natera, a medical molecular testing product in the United States, with a global market size of up to 59 billion US dollars.
With the success of CircleDNA among consumers, CircleMedical will become the only product for doctors, specifically designed to meet their professional needs, such as heart health and carrier screening. Invitae has pioneered medical genetic testing in the United States, and Prenetics hopes to do the same in Hong Kong, the UK, and Southeast Asia.
According to Frost & Sullivan's forecast, Circle Medical is expected to grow at a rate of 47% over the next 3 years and will bring Prenetics sales revenue of 225 million US dollars by 2025.
0 nhận xét:
Đăng nhận xét